Oklahoma inmate dies from heart attack after botched execution
Oklahoma Department of Corrections
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
You are now subscribed
Your newsletter sign-up was successful
An Oklahoma death row inmate died Tuesday night from a heart attack after officials botched the delivery of a new lethal drug combination that was supposed to kill him.
The New York Times reports that Clayton D. Lockett "began to twitch and gasp" after a doctor had deemed he was unconscious, about 20 minutes after the first drug was administered. Witnesses said that Lockett mumbled "oh man" and tried to lift his head, before the doctor discovered that "the line had blown" and that the drugs, especially the sedative, were no longer entering his bloodstream. His lawyers question the failed veins explanation from prison officials.
Lockett was set to be the first of two inmates put to death Tuesday night, but after the botched execution, Director of Corrections Robert Patton requested a 14-day stay for the second inmate, Charles F. Warner. Gov. Mary Fallin (R) approved the request.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Both Lockett and Warner had earlier tried to delay the executions over Oklahoma's refusal to disclose the source of the new drugs that would be used in the injections. The Times reports that Lockett was set to first be injected with midazolam, which would make him unconscious and unable to feel pain. The second injection would have been of vecuronium bromide, which stops breathing, and the third of potassium chloride, which stops the heart. Florida has used a similar combination to execute prisoners, but with a higher dosage of midazolam.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
